Avoro Capital Advisors LLC 13D and 13G filings for Fennec Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 10:08 am Sale | 2021-12-31 | 13G | Fennec Pharmaceuticals Inc. FENC | Avoro Capital Advisors LLC | 1,200,000 4.600% | -470,000 (-28.14%) | Filing |
| 2021-02-12 08:01 am Purchase | 2020-12-31 | 13G | Fennec Pharmaceuticals Inc. FENC | Avoro Capital Advisors LLC | 1,670,000 6.500% | 564,001 (+50.99%) | Filing |